Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutgers

Showing results (691-700 of 982) with videos related to

Pageof 99
Sort By:
The British Journal of Surgery|May 20, 2017
Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapyB B Koolen, M Donker, M E Straver, et al.
Rheumatology (Oxford, England)|November 17, 2018
Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11β-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptorArno C Hessels, Janneke Tuin, Jan Stephan F Sanders, et al.
Nuclear Medicine Communications|January 3, 2019
Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancerDaan Hellingman, Oi Yan Wan, Berlinda J de Wit-van der Veen, et al.
Technical Innovations & Patient Support in Radiation Oncology|January 1, 2024
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-LinacS R de Mol van Otterloo, J M Westerhoff, T Leer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2006
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group, , Nina Bijker, et al.
Medicine|September 17, 2015
Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for StandardizationMenno D Stellingwerff, Elisabeth Brouwer, Karel-Jan D F Lensen, et al.
Pain|August 16, 2005
A longitudinal study on the predictive validity of the fear-avoidance model in low back painJudith M Sieben, Johan W S Vlaeyen, Piet J M Portegijs, et al.
Journal of Abnormal Child Psychology|May 17, 2007
Autism, attachment and parenting: a comparison of children with autism spectrum disorder, mental retardation, language disorder, and non-clinical childrenAnna H Rutgers, Marinus H van Ijzendoorn, Marian J Bakermans-Kranenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trialMila Donker, Saskia Litière, Gustavo Werutsky, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 25, 2015
The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetiumM E M van der Noordaa, K E Pengel, E Groen, et al.
Pageof 99

Showing results (691-700 of 982) with videos related to

Sort By:
Pageof 99
The British Journal of Surgery|May 20, 2017
Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapyB B Koolen, M Donker, M E Straver, et al.
Rheumatology (Oxford, England)|November 17, 2018
Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11β-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptorArno C Hessels, Janneke Tuin, Jan Stephan F Sanders, et al.
Nuclear Medicine Communications|January 3, 2019
Predictive risk factors for sentinel lymph node nonvisualization on planar lymphoscintigraphy using an intratumoral injection in patients with primary breast cancerDaan Hellingman, Oi Yan Wan, Berlinda J de Wit-van der Veen, et al.
Technical Innovations & Patient Support in Radiation Oncology|January 1, 2024
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-LinacS R de Mol van Otterloo, J M Westerhoff, T Leer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2006
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group, , Nina Bijker, et al.
Medicine|September 17, 2015
Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for StandardizationMenno D Stellingwerff, Elisabeth Brouwer, Karel-Jan D F Lensen, et al.
Pain|August 16, 2005
A longitudinal study on the predictive validity of the fear-avoidance model in low back painJudith M Sieben, Johan W S Vlaeyen, Piet J M Portegijs, et al.
Journal of Abnormal Child Psychology|May 17, 2007
Autism, attachment and parenting: a comparison of children with autism spectrum disorder, mental retardation, language disorder, and non-clinical childrenAnna H Rutgers, Marinus H van Ijzendoorn, Marian J Bakermans-Kranenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trialMila Donker, Saskia Litière, Gustavo Werutsky, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 25, 2015
The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetiumM E M van der Noordaa, K E Pengel, E Groen, et al.
Pageof 99